HIGH-RISK MYELODYSPLASTIC SYNDROME (MDS)
Clinical trials for HIGH-RISK MYELODYSPLASTIC SYNDROME (MDS) explained in plain language.
Never miss a new study
Get alerted when new HIGH-RISK MYELODYSPLASTIC SYNDROME (MDS) trials appear
Sign up with your email to follow new studies for HIGH-RISK MYELODYSPLASTIC SYNDROME (MDS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental CAR t therapy takes on tough leukemia
Disease control Recruiting nowThis early-phase trial tests a new treatment called CD64 CAR T cells for adults with acute myeloid leukemia (AML) that has come back or not responded to standard therapy. The treatment uses a patient's own immune cells, modified in a lab to target and attack leukemia cells. The m…
Matched conditions: HIGH-RISK MYELODYSPLASTIC SYNDROME (MDS)
Phase: PHASE1 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Scientists launch biobank to unlock secrets of leukemia
Knowledge-focused Recruiting nowThis study is creating a collection of blood and bone marrow samples from 1,000 adults with acute myeloid leukemia, acute lymphoblastic leukemia, or high-risk myelodysplastic syndrome. The samples will be used by researchers to better understand these diseases and find new ways t…
Matched conditions: HIGH-RISK MYELODYSPLASTIC SYNDROME (MDS)
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC